Patent · US Expired

Cancer-associated antigens and methods of their identification and use

US7217421B1 · kind B1 · utility

18Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2000
Grant dateMay 15, 2007
Priority date
Expiry dateJul 6, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/5156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.